Quick Answer
Marker Therapeutics, Inc. reported Total Revenue of $213.2 thousand for the year ending 2019.
- Marker Therapeutics, Inc. showed an increase of +3.5% in Total Revenue from 2018 to 2019.
- This data is from Marker Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2020.
- XBRL data for this metric is available from 2017 to 2019 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2017: $0.00 | Q3 2017: $183.1 thousand | Q2 2018: $206.0 thousand | Q3 2018: $0.00 | Q2 2019: $0.00 | Q3 2019: $0.00.
- Over the full 3 years of available data (2017 to 2019), Marker Therapeutics, Inc.'s Total Revenue has grown by 16.5%.
- Historical annual values: Fiscal year 2019: $213.2 thousand | Fiscal year 2018: $206.0 thousand | Fiscal year 2017: $183.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: